DYRK1A BAC Transgenic Mouse: A New Model of Thyroid Dysgenesis in Down Syndrome
The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
The most common thyroid abnormality among Down syndrome (DS) children corresponds to a mildly elevated TSH, with T4 decreased or in the normal range and thyroid hypoplasia, from the neonatal period onward, which aggravate their mental impairment. Transgenic Dyrk1A mice, obtained by bacterial artificial chromosome engineering (mBACTgDyrk1A), have 3 copies of the Dyrk1A gene. The objective is to determine whether this transgenic Dyrk1A (Dyrk1A+/++) mouse is an adequate murine model for the study of thyroid dysgenesis in DS. Embryonic thyroid development from embryonic day 13.5 (E13.5) to E17.5 was analyzed in wild-type (WT) and Dyrk1A+/++ mice by immunofluorescence with anti-Nkx2–1, anti-thyroglobulin, and anti-T4 antibodies, markers of early thyroid development, hormonogenesis, and final differentiation, respectively. The expression of transcription factors Nkx2–1, Pax8, and Foxe1 involved in thyroidogenesis were studied by quantitative RT-PCR at the same embryonic stages. We then compared the adult phenotype at 8 to 12 weeks in Dyrk1A+/++ and WT mice for T4 and TSH levels, thyroidal weight, and histological analysis. Regarding thyroidal development, at E15.5, Dyrk1A+/++ thyroid lobes are double the size of WT thyroids (P = .01), but the thyroglobulin stained surface in Dyrk1A+/++ thyroids is less than a third as large at E17.5 (P = .04) and their differentiated follicular surface half the size (P = .004). We also observed a significant increase in Nkx2–1, Foxe1, and Pax8 RNA levels in E13.5 and E17.5 Dyrk1A+/++ embryonic thyroids. Dyrk1A+/++ young adult mice have significantly lower plasma T4 (2.4 ng/mL versus WT, 3.7 ng/mL; P = 0.019) and nonsignificantly higher plasma TSH (114 mUI/L versus WT, 73mUI/L; P = .09). In addition, their thyroids are significantly heavier (P = .04) and exhibit large disorganized regions. Dyrk1A overexpression directly leads to thyroidal embryogenetic, functional and morphological impairment. The young adult thyroid phenotype is probably a result of embryogenetic impairment. The Dyrk1A+/++ mouse can be considered a suitable study model for thyroid dysgenesis in DS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The probable cause of both phenomena is TD, probably related to the extra chromosome 21 and possibly to overexpression of the DYRK1A gene (40–43).”
In the citing paper
“With respect to the cause of the mild nonautoimmune subclinical hypothyroidism in neonates and infants with Down's syndrome, new insights were provided by a study in Dyrk1A (+/++) mice, showing abnormal thyroid development and function (42).”
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Singh, B. N., Shankar, S., & Srivastava, R. K. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.093 · Cited by 1,602
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21
Arron, J. R., Winslow, M. M., Polleri, A., Chang, C.-P., Wu, H., Gao, X., Neilson, J. R., Chen, L., Heit, J. J., Kim, S. K., et al. (2006) · Nature · doi:10.1038/nature04678 · Cited by 698
Léger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1891 · Cited by 569
Self-citationAltafaj, X. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.18.1915 · Cited by 396
De la Torre, R., De Sola, S., Pons, M., Duchon, A., de Lagran, M. M., Farré, M., Fitó, M., Benejam, B., Langohr, K., Rodriguez, J., et al. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300325 · Cited by 286
Self-citationThyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity
Karlsson, B., Gustafsson, J., Hedov, G., Ivarsson, S.-A., & Anneren, G. (1998) · Archives of Disease in Childhood · doi:10.1136/adc.79.3.242 · Cited by 279
DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects
Ahn, K.-J., Jeong, H. K., Choi, H.-S., Ryoo, S.-R., Kim, Y. J., Goo, J.-S., Choi, S.-Y., Han, J.-S., Ha, I., & Song, W.-J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.006 · Cited by 220
Green Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A
Guedj, F., Sébrié, C., Rivals, I., Ledru, A., Paly, E., Bizot, J. C., Smith, D., Rubin, E., Gillet, B., Arbones, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004606 · Cited by 216
Self-citationAbnormalities of thyroid function in infants with Down syndrome
Fort, P., Lifshitz, F., Bellisario, R., Davis, J., Lanes, R., Pugliese, M., Richman, R., Post, E. M., & David, R. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80544-2 · Cited by 212
Function and regulation of Dyrk1A: towards understanding Down syndrome
Park, J., Song, W.-J., & Chung, K. C. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0123-2 · Cited by 205
An integrated regulatory network controlling survival and migration in thyroid organogenesis
Parlato, R., Rosica, A., Rodriguez-Mallon, A., Affuso, A., Postiglione, M. P., Arra, C., Mansouri, A., Kimura, S., Di Lauro, R., & De Felice, M. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.08.048 · Cited by 179
DYRK1A: A master regulatory protein controlling brain growth
Guedj, F., Pereira, P. L., Najas, S., Barallobre, M.-J., Chabert, C., Souchet, B., Sebrie, C., Verney, C., Herault, Y., Arbones, M., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.01.007 · Cited by 158
Self-citationThe Protein Kinase DYRK1A Regulates Caspase-9-Mediated Apoptosis during Retina Development
Laguna, A., Aranda, S., Barallobre, M. J., Barhoum, R., Fernández, E., Fotaki, V., Delabar, J. M., de la Luna, S., de la Villa, P., & Arbonés, M. L. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.10.014 · Cited by 157
Self-citationPOHLENZ, J., MAQUEEM, A., CUA, K., WEISS, R. E., VAN SANDE, J., & REFETOFF, S. (1999) · Thyroid · doi:10.1089/thy.1999.9.1265 · Cited by 154
Hämmerle, B., Ulin, E., Guimera, J., Becker, W., Guillemot, F., & Tejedor, F. J. (2011) · Development · doi:10.1242/dev.066167 · Cited by 137
Lower Neonatal Screening Thyroxine Concentrations in Down Syndrome Newborns
van Trotsenburg, A. S. P., Vulsma, T., van Santen, H. M., Cheung, W., & de Vijlder, J. J. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021303 · Cited by 118
Dierssen, M., & de Lagrán, M. M. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.319 · Cited by 97
Minireview: Intrinsic and Extrinsic Factors in Thyroid Gland Development: An Update
De Felice, M., & Di Lauro, R. (2011) · Endocrinology · doi:10.1210/en.2011-0204 · Cited by 92
School based screening for hypothyroidism in Down's syndrome by dried blood spot TSH measurement
Noble, S. E., Leyland, K., Findlay, C. A., Clark, C. E., Redfern, J., Mackenzie, J. M., Girdwood, R. W., & Donaldson, M. D. (2000) · Archives of Disease in Childhood · doi:10.1136/adc.82.1.27 · Cited by 86
Glucose Is Necessary for Embryonic Pancreatic Endocrine Cell Differentiation
Guillemain, G., Filhoulaud, G., Xavier, G. D. S., Rutter, G. A., & Scharfmann, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610986200 · Cited by 77
Self-citationl -Leucine Alters Pancreatic β-Cell Differentiation and Function via the mTor Signaling Pathway
Rachdi, L., Aïello, V., Duvillié, B., & Scharfmann, R. (2012) · Diabetes · doi:10.2337/db11-0765 · Cited by 70
Self-citationProfile of Hypothyroidism in Down’s Syndrome
Cebeci, A. N., Güven, A., & Metin, Y. (2013) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.884 · Cited by 69
Plasma thyrotropin bioactivity in Down's syndrome children with subclinical hypothyroidism
Konings, C., van Trotsenburg, A., Ris-Stalpers, C., Vulsma, T., Wiedijk, B., & de Vijlder, J. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440001 · Cited by 62
Noll, C., Planque, C., Ripoll, C., Guedj, F., Díez-Betriu, A., Ducros, V., Belin, N., Duchon, A., Paul, J., Badel, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007540 · Cited by 57
Self-citationDyrk1A induces pancreatic β cell mass expansion and improves glucose tolerance
Rachdi, L., Kariyawasam, D., Aïello, V., Hérault, Y., Janel, N., Delabar, J. M., Polak, M., & Scharfmann, R. (2014) · Cell Cycle · doi:10.4161/cc.29250 · Cited by 56
Self-citationTriplication of DYRK1A causes retinal structural and functional alterations in Down syndrome
Laguna, A., Barallobre, M.-J., Marchena, M.-Á., Mateus, C., Ramírez, E., Martínez-Cue, C., Delabar, J. M., Castelo-Branco, M., de la Villa, P., & Arbonés, M. L. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt125 · Cited by 55
Self-citationCarré, A., Hamza, R. T., Kariyawasam, D., Guillot, L., Teissier, R., Tron, E., Castanet, M., Dupuy, C., El Kholy, M., & Polak, M. (2014) · Thyroid · doi:10.1089/thy.2013.0417 · Cited by 49
Self-citationCarre, A., Rachdi, L., Tron, E., Richard, B., Castanet, M., Schlumberger, M., Bidart, J.-M., Szinnai, G., & Polak, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016752 · Cited by 47
Self-citationDyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic beta cell mass
Rachdi, L., Kariyawasam, D., Guez, F., Aïello, V., Arbonés, M. L., Janel, N., Delabar, J. M., Polak, M., & Scharfmann, R. (2014) · Diabetologia · doi:10.1007/s00125-014-3174-3 · Cited by 44
Self-citationSubclinical hypothyroidism in the first years of life in patients with Down syndrome
Claret, C., Goday, A., Benaiges, D., Chillarón, J. J., Roux, J. A. F., Hernandez, E., Corretger, J. M., & Cano-Pérez, J. F. (2013) · Pediatric Research · doi:10.1038/pr.2013.26 · Cited by 43
Tirosh, E., Taub, Y., Scher, A., Jaffe, M., & Hochberg, Z. (1989) · PubMed · Cited by 35
Thyroid Function in Fetuses with Down Syndrome
Luton, D., Azria, É., Polak, M., Carré, A., VUILLARD, E., Delezoide, A., & Guibourdenche, J. (2012) · Hormone Research in Paediatrics · doi:10.1159/000341149 · Cited by 27
Self-citationRole for VPAC2 Receptor-Mediated Signals in Pancreas Development
Rachdi, L., Marie, J., & Scharfmann, R. (2003) · Diabetes · doi:10.2337/diabetes.52.1.85 · Cited by 26
Self-citationThyroid functions of neonates with Down syndrome
Sarıcı, D., Akın, M. A., Kurtoğlu, S., Güneş, T., Ozturk, M., & Akçakuş, M. (2012) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/1824-7288-38-44 · Cited by 24
Increased neonatal thyrotropin in Down syndrome
Myrelid, Å., Jönsson, B., Guthenberg, C., von Döbeln, U., Annerén, G., & Gustafsson, J. (2009) · Acta Paediatrica · doi:10.1111/j.1651-2227.2009.01245.x · Cited by 22
Souchet, B., Latour, A., Gu, Y., Daubigney, F., Paul, J., Delabar, J. M., & Janel, N. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0324-5 · Cited by 16
Self-citationNishimura, G., Harigaya, A., Kuwashima, M., & Kuwashima, S. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19970711)71:1
Research works printed but not linked: 1
- Roberts, 1997, Population study of congenital hypothyroidism and associated birth defects, Atlanta, 1979–1992, Am J Med Genet, 71, 29, 10.1002/(SICI)1096-8628(19970711)71:1<29::AID-AJMG5>3.0.CO;2-L · doi:10.1002/(sici)1096-8628(19970711)71:1<29::aid-ajmg5>3.0.co;2-l
Cited by
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
“With respect to the cause of the mild nonautoimmune subclinical hypothyroidism in neonates and infants with Down’s syndrome, new insights were provided by a study in Dyrk1A (+/++) mice, showing abnormal thyroid development and function (42).”
BackgroundSelf-citationDevelopment of the thyroid gland
Nilsson, M., & Fagman, H. (2017) · Development · doi:10.1242/dev.145615 · Cited by 286
“The need for tight control of thyroid cell proliferation is emphasized by recent observations in a mouse model of Down syndrome in which overexpression of Dyrk1a, the candidate gene for the trisomy 21 phenotype, leads to fetal thyroid hyperplasia and increased final thyroid size (Kariyawasam et al., 2015).”
BackgroundInfluentialDierssen, M., Fructuoso, M., Martínez de Lagrán, M., Perluigi, M., & Barone, E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00670 · Cited by 101
TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology
Stoupa, A., Adam, F., Kariyawasam, D., Strassel, C., Gawade, S., Szinnai, G., Kauskot, A., Lasne, D., Janke, C., Natarajan, K., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201809569 · Cited by 71
“The sections were then analysed using ImageJ 1.32s (freeware, www.rsbweb.nih.gov/ij) as previously described (Carre et al, 2011; Kariyawasam et al, 2015).”
MethodSelf-citationNew genetics in congenital hypothyroidism
Stoupa, A., Kariyawasam, D., Muzza, M., de Filippis, T., Fugazzola, L., Polak, M., Persani, L., & Carré, A. (2021) · Endocrine · doi:10.1007/s12020-021-02646-9 · Cited by 59
“New insights were provided by a study in Dyrk1A(+/++) mice showing abnormal thyroid development and function [12].”
BackgroundSelf-citation
Metadata
- Authors
- Kariyawasam, D., Rachdi, L., Carré, A., Martin, M., Houlier, M., Janel, N., Delabar, J.-M., Scharfmann, R., & Polak, M.
- Affiliations
- Hôpital Necker-Enfants Malades (FR)
- Inserm (FR)
- Diabetes and Obesity Research Laboratory (M.M.), Institut d'Investigacions Biomèdiques August Pi I Sunyer, 08036 Barcelona, Spain
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Polak, Michel
- ORCID
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2015-03-01
- Volume
- 156
- Issue
- 3
- Pages
- 1171-1180
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2015639284
- Cited by
- 30
- References
- 39
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 4 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 3
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institute of Genetics
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- Down syndrome, DYRK1A, thyroid dysgenesis, thyroid hypoplasia, transgenic mouse model, bacterial artificial chromosome, thyroid development, thyroglobulin, TTF-1, PAX8, FOXE1, thyroxine, thyroid-stimulating hormone, intellectual disability
- MeSH terms
- Dyrk Kinases, Animals, Disease Models, Animal, Down Syndrome, Female, Humans, Mice, Transgenic, Protein-Tyrosine Kinases, Thyroid Gland, Protein Serine-Threonine Kinases, Gene Expression Regulation, Developmental, Chromosomes, Artificial, Bacterial, Thyroid Dysgenesis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.